SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · PPR

NöroAid: Parkinson ve Depresyon Riski Tahmini için Açık Veri Multimodal Tarama Çerçevesi

NeuroAid: An Open-Data Multimodal Screening Framework for Parkinson’s and Depression Risk Estimation

Makine çevirisi · Editoryal inceleme bekliyor

· 2026-08-04

DOI: 10.64898/2026.08.03.26359539

Erişim kaynaktan kontrol edilmeliPreprintKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Neurological and mental-health conditions such as Parkinson’s disease (PD) and major depressive disorder (MDD) impose a substantial and growing global burden, yet reliable early screening remains largely confined to specialist clinical settings that are inaccessible to the majority of affected individuals. We present NeuroAid, an open-data multimodal AI screening framework that estimates condition-specific risk from non-invasive, accessible signals spanning acoustic speech biomarkers, facial and video-based affective cues, and clinical or behavioral digital biomarkers. NeuroAid is organized as a modular, branch-wise pipeline covering three independent signal pathways—audio, vision, and behavioral—unified by a frozen-embedding late-fusion layer that produces interpretable joint risk scores. A participant-safe, subject-grouped splitting protocol is enforced throughout, preventing inter-subject data leakage—a frequently overlooked cause of artificially inflated performance in clinical machine learning benchmarks. On the Figshare Parkinson’s audio dataset, a proposed small-data protocol combining frozen WavLM foundation-model embeddings with a grouped SVM-RBF classifier achieves a cross-validated balanced accuracy of 0.786±0.073 and a held-out test balanced accuracy of 75.0%, F1-score of 80.0%, and AUC-ROC of 82.8%. The depression vision branch, trained on the DepVidMood corpus via transfer from FER-2013, reaches a threshold-tuned test balanced accuracy of 59.7% and is presented as an honest hard-case baseline under severe class imbalance. NeuroAid is further distinguished by its production-grade MLOps scaffolding: orchestrated branch training, JSON and Markdown artifact reporting, a deployable Streamlit screening interface, and a complete CI/CD workflow. The entire system is built exclusively on publicly available datasets, ensuring full reproducibility. All code, artifacts, and benchmark outputs are versioned and deployable via Docker.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.